Back to search
FDAFDA · Food and drugs·Recall number D-0857-2018

Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30)

Published May 30, 2018 · Recall initiated: April 30, 2018

Summary

FDA records drug Class III recall D-0857-2018, published May 30, 2018 and initiated April 30, 2018. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 30,382 patches; Lot: Carton Lot Number:1147020B Patch (Envelope) Lot Number: 1147020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if LIDOCAINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LIDOCAINE
Manufacturer
Teva Pharmaceuticals USA
Distributor
United States
Lot
Carton Lot Number:1147020B Patch (Envelope) Lot Number: 1147020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30) recalled?

Yes. FDA published recall D-0857-2018 on May 30, 2018. Reported hazard: Failed Stability Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LIDOCAINE.